These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 15225884

  • 21. [Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].
    Richter C, Romanowski A, Kienast T.
    Psychiatr Prax; 2009 Oct; 36(7):345-7. PubMed ID: 19173170
    [Abstract] [Full Text] [Related]

  • 22. Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam.
    Nava F, Premi S, Manzato E, Campagnola W, Lucchini A, Gessa GL.
    Am J Drug Alcohol Abuse; 2007 Oct; 33(3):379-92. PubMed ID: 17613965
    [Abstract] [Full Text] [Related]

  • 23. Gamma-hydroxybutyrate (GHB): a newer drug of abuse.
    O'Connell T, Kaye L, Plosay JJ.
    Am Fam Physician; 2000 Dec 01; 62(11):2478-83. PubMed ID: 11130233
    [Abstract] [Full Text] [Related]

  • 24. [Liquid ecstasy in general psychiatry: a case series].
    Freudenmann RW, Baumgarten E, Hawlik AE, Gahr M, Schönfeldt-Lecuona CJ.
    Fortschr Neurol Psychiatr; 2013 Feb 01; 81(2):88-94. PubMed ID: 23412960
    [Abstract] [Full Text] [Related]

  • 25. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
    Craig K, Gomez HF, McManus JL, Bania TC.
    J Emerg Med; 2000 Jan 01; 18(1):65-70. PubMed ID: 10645841
    [Abstract] [Full Text] [Related]

  • 26. Seven days of gamma-hydroxybutyrate (GHB) use produces severe withdrawal.
    Perez E, Chu J, Bania T.
    Ann Emerg Med; 2006 Aug 01; 48(2):219-20. PubMed ID: 16857475
    [No Abstract] [Full Text] [Related]

  • 27. Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.
    Marinelli E, Beck R, Malvasi A, Lo Faro AF, Zaami S.
    Arh Hig Rada Toksikol; 2020 Mar 01; 71(1):19-26. PubMed ID: 32597141
    [Abstract] [Full Text] [Related]

  • 28. [Detoxification of patients with GHB dependence].
    de Weert-van Oene GH, Schellekens AF, Dijkstra BA, Kamal R, de Jong CA.
    Tijdschr Psychiatr; 2013 Mar 01; 55(11):885-90. PubMed ID: 24242149
    [Abstract] [Full Text] [Related]

  • 29. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
    Moitroux A, Kestens C.
    Rev Med Liege; 2023 Jul 01; 78(7-8):451-455. PubMed ID: 37560960
    [Abstract] [Full Text] [Related]

  • 30. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
    Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R.
    Am J Addict; 2001 Jul 01; 10(3):232-41. PubMed ID: 11579621
    [Abstract] [Full Text] [Related]

  • 31. Gamma-hydroxybutyrate--a drug of abuse.
    Drasbek KR, Christensen J, Jensen K.
    Acta Neurol Scand; 2006 Sep 01; 114(3):145-56. PubMed ID: 16911342
    [Abstract] [Full Text] [Related]

  • 32. [Gamma-hydroxybutyrate--a neurotransmitter, medicine, and drug].
    Trendelenburg G, Ströhle A.
    Nervenarzt; 2005 Jul 01; 76(7):832, 834-8. PubMed ID: 15580464
    [Abstract] [Full Text] [Related]

  • 33. Baclofen and gamma-hydroxybutyrate withdrawal.
    LeTourneau JL, Hagg DS, Smith SM.
    Neurocrit Care; 2008 Jul 01; 8(3):430-3. PubMed ID: 18266111
    [Abstract] [Full Text] [Related]

  • 34. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C, Pichini S, Spagnolo EV, Calapai F, Gangemi S, Navarra M, Calapai G.
    Curr Drug Metab; 2018 Jul 01; 19(13):1056-1064. PubMed ID: 29219048
    [Abstract] [Full Text] [Related]

  • 35. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
    Habibian S, Ahamad K, McLean M, Socias ME.
    J Addict Med; 2019 Jul 01; 13(5):415-417. PubMed ID: 30907765
    [Abstract] [Full Text] [Related]

  • 36. [Variety of symptoms after drug use of gamma-hydroxybutyric acid (GHB)].
    Galldiks N, Kadow I, Bechdolf A, Fink GR, Klosterkötter J, Kuhn J.
    Fortschr Neurol Psychiatr; 2011 Jan 01; 79(1):21-5. PubMed ID: 21154180
    [Abstract] [Full Text] [Related]

  • 37. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review.
    Siefried KJ, Freeman G, Roberts DM, Lindsey R, Rodgers C, Ezard N, Brett J.
    Psychopharmacology (Berl); 2023 Jan 01; 240(1):127-135. PubMed ID: 36508055
    [Abstract] [Full Text] [Related]

  • 38. Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose.
    van Amsterdam JG, Brunt TM, McMaster MT, Niesink RJ.
    Neurosci Biobehav Rev; 2012 Apr 01; 36(4):1217-27. PubMed ID: 22342779
    [Abstract] [Full Text] [Related]

  • 39. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
    Wojtowicz JM, Yarema MC, Wax PM.
    CJEM; 2008 Jan 01; 10(1):69-74. PubMed ID: 18226321
    [Abstract] [Full Text] [Related]

  • 40. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
    Palmer RB.
    Toxicol Rev; 2004 Jan 01; 23(1):21-31. PubMed ID: 15298490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.